Browsing by Author "Özbek N.Y."

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Common viral respiratory infections in children with cancer during the COVID-19 pandemic: a multicenter study from Türkiye
    (Turkish National Pediatric Society, 2024) Kaçar D.; Kebudi R.; Özyörük D.; Tuğcu D.; Bahadır A.; Özdemir Z.C.; Özgüven A.A.; Orhan M.F.; Yıldırım A.T.; Albayrak C.; Kartal İ.; Sarı N.; Tokgöz H.; Albayrak M.; Ayhan A.C.; Eroğlu N.; Aydın S.; Üzel V.H.; Zülfikar B.; Yıldırım Ü.M.; Büyükavcı M.; Gülen H.; Töret E.; Bör Ö.; Özbek N.Y.; İlhan İ.E.; Yaralı N.
    Background. Microbiologic confirmation of respiratory tract infections gained importance during the coronavirus disease 2019 (COVID-19) pandemic. This study retrospectively evaluated seasonal distribution, clinical presentation, and complications of respiratory viral infections (RVIs) other than COVID-19 in children with cancer during and after the pandemic lockdown. Methods. Two hundred and sixty-five inpatient and outpatient RVI episodes in 219 pediatric cancer patients confirmed by multiplex reverse transcriptase polymerase chain reaction (RT-PCR) panels from 13 centers were enrolled. Results. Eighty-six (32.5%) of the total 265 episodes occurred in 16 months corresponding to the lockdowns in Türkiye, and the remaining 67.5% in 10 months thereafter. Human rhinovirus/enterovirus (hRE) (48.3%) was the most common agent detected during and after lockdown. Parainfluenza virus (PIV) (23.0%), influenza virus (9.8%), and respiratory syncytial virus (RSV) (9.1%) were the other common agents. The 28.7% of episodes were lower respiratory tract infections (LRTIs), and complications and mortality were higher than upper respiratory tract infections (URTIs) (25.0% vs 5.3%). Bacteremia was identified in 11.5% of culture-drawn episodes. Treatment delay in one-third and death within four weeks after RVI in 4.9% of episodes were observed. Conclusion. During the pandemic, fewer episodes of RVIs occurred during the lockdown period. Respiratory viruses may cause complications, delays in treatment, and even death in children with cancer. Therefore, increased awareness of RVIs and rapid detection of respiratory viruses will benefit the prevention and, in some cases, abrupt supportive and some antiviral treatment of RVI in children with cancer. © 2024, Turkish National Pediatric Society. All rights reserved.